Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades9,036
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions1
GSK
Media
GSK Company
Research
GSK Company
Timeline1
Share Price Information for Glaxosmithkline (GSK)
Last checked at -
Last checked at 
Intraday Glaxosmithkline Share Chart
Glaxosmithkline News
Sales jump at GSK on strong demand for specialty drugs
(Sharecast News) - GSK posted above-forecast first-quarter profits on Wednesday, boosted by robust demand for its specialist HIV and oncology drugs.
LONDON BRIEFING: AstraZeneca, Lloyds, GSK post first-quarter growth
(Alliance News) - AstraZeneca, Lloyds Banking Group and GSK report higher earnings in the first quarter.
GSK beats quarterly profit estimates on strength in respiratory, general medicines
LONDON, April 29 (Reuters) - British drugmaker GSK reported first-quarter profit above analysts' expectations on Wednesday, helped by strong s...
IN BRIEF: GSK given fast-track review by US FDA for hepatitis B drug
GSK PLC - London-based pharmaceuticals maker - Bepirovirsen, GSK's treatment for chronic hepatitis B, is accepted for priority review and given 'break...
GSK hepatitis B drug secures FDA priority review
(Sharecast News) - Pharmaceutical giant GSK said on Tuesday that the US Food and Drug Administration had accepted its new drug application for bepirov...
GSK's liver treatment efimosfermin makes US, EU regulatory progress
(Alliance News) - GSK PLC on Monday announced two positive regulatory rulings for efimosfermin, a once-monthly investigational liver therapy.
US court dismisses part of GSK subsidiary's licence dispute claim
(Alliance News) - GSK PLC on Monday said a US court has dismissed part of a legal claim involving its subsidiary Tesaro Inc.
Follow the stocks
